Find your path to Bruce
296 people in our graph share verified history with Bruce — schools, employers, funds. One of them is your warm intro.
About
Dr. Bruce Taylor is Co-Founder of PredxBio and holds appointments at the University of Pittsburgh School of Medicine, where he serves as Distinguished Professor, Allegheny Foundation Professor of Computational and Systems Biology, and Senior Member of the Organ Pathobiology and Therapeutics Institute. His work applies quantitative systems pharmacology and patient digital twins to drug discovery in liver-related conditions, including metabolic dysfunction-associated steatotic liver disease, Type 2 Diabetes, and breast and melanoma metastases in the liver, using human microphysiology systems and computational systems pathology. He has worked in academia at Harvard, Carnegie Mellon University, and the University of Pittsburgh, and has founded or led biotechnology companies including Cellomics, Cellumen, Cernostics, PredxBio, and Biosystics.
Founder at SpIntellx
Intro paths
In turn, Bruce can intro founders to SpIntellx's investors below.
SpIntellx's investors · 2
Co-founders at SpIntellx
Co-founder, Scientific & Business Advisor at Predxbio
Intro paths
In turn, Bruce can intro founders to Predxbio's investors below.
Predxbio's investors · 5
Co-founders at Predxbio
Experience
- PredxBioCo-Foundercurrent2019 — presentUnited States
- University of PittsburghDirector, Univ of Pitt Drug Discovery Institute & Allegheny Foundation and Distinguished Professor2010 — 2024Greater Pittsburgh Area
- BioSystics, Inc.Chairman of the Board2021 — 2023United States
- CernosticsCo-Founder and Board Member2009 — 2011Pittsburgh, Pennsylvania, United States
- CellumenCEO2004 — 2010
- CellomicsCEO1996 — 2003
- Carnegie Mellon UniversityProfessor of Biological Sciences, Director, Science and Technology Center1982 — 1996Greater Pittsburgh Area
- Harvard UniversityAssociate Professor1974 — 1982United States
Skills & more
+12 more
PhotoshopTeachingHTMLBudgetsC++Public SpeakingBiochemistryBiotechnologyCell BiologyData AnalysisCell CultureDrug DiscoveryLanguages German
From Bruce's professional profile.
Frequently asked questions
- Who is Bruce?
- Dr. Bruce Taylor is Co-Founder of PredxBio and holds appointments at the University of Pittsburgh School of Medicine, where he serves as Distinguished Professor, Allegheny Foundation Professor of Computational and Systems Biology, and Senior Member of the Organ Pathobiology and Therapeutics Institute. His work applies quantitative systems pharmacology and patient digital twins to drug discovery in liver-related conditions, including metabolic dysfunction-associated steatotic liver disease, Type 2 Diabetes, and breast and melanoma metastases in the liver, using human microphysiology systems and computational systems pathology. He has worked in academia at Harvard, Carnegie Mellon University, and the University of Pittsburgh, and has founded or led biotechnology companies including Cellomics, Cellumen, Cernostics, PredxBio, and Biosystics.
- Where does Bruce work?
- Bruce is Co-founder, Scientific & Business Advisor of Predxbio and Co-founder at SpIntellx.
- What companies did Bruce found?
- Bruce founded Predxbio, SpIntellx.
- Where did Bruce go to school?
- Bruce studied at University at Albany (Doctor of Philosophy - PhD, Biological Sciences).
Founder mafias
Carnegie Mellon University mafia481
Also came through, then founded or led a company.
+ 474 more
University at Albany mafia19
Also came through, then founded or led a company.
+ 12 more
Same school
Also attended University at Albany124
+ 118 more
Shared employers
Also worked at PredxBio2
Also worked at University of Pittsburgh74
+ 68 more
Also worked at Carnegie Mellon University268
+ 262 more
Also worked at Harvard University487
+ 481 more